Rule/Regulation Violated:
B. If an assisted living facility provides medication administration, a manager shall ensure that:
3. A medication administered to a resident:
b. Is administered in compliance with a medication order, and
Evidence/Findings:
Based on record review and interview, the manager failed to ensure medication administered to a resident was administered in compliance with a medication order, for one of two residents sampled. The deficient practice posed a risk if a resident experienced a change in condition due to improper medication administration.
Findings include:
1. A review of R2's medical record revealed a current service plan for personal care services. The service plan revealed R2 received medication administration.
2. The Compliance Officer observed a bottle of "Trazadone 50 mg (milligrams) tablets", a bottle of "Escitalopram 10 mg", and a bottle of "Donepezil 10 mg" in a medication box belonging to R2.
3. A review of R2's medical record revealed medication orders for "Trazadone 50 mg tablets" and "Escitalopram 10 mg" were unavailable for review. R2's medical record contained a medication order for "Donepezil 10 mg, 1 tablet by mouth HS."
4. A review of R2's medical record revealed a medication administration record (MAR) dated July 2023. R2's July 2023 MAR revealed "Trazadone 50 mg" was documented as administered on July 1-26, 2023, at 6:00 PM, "Escitalopram 10 mg" was documented as administered on July 1-25, 2023 at 6:00 PM, and "Donepezil 10 mg, 2 tablets" was documented as administered on July 1-25, 2023, at 6:00 PM.
5. In an interview, E1 reported the medication orders for "Trazadone 50 mg" and "Escitalopram 10 mg" were not available for review. E1 acknowledged "Donepezil 10 mg" was not administered to R2 in compliance with the medication order.
Summary:
The following deficiencies were found during the on-site compliance inspection conducted on July 27, 2023: